COPN — Cosmo Pharmaceuticals NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Cosmo Pharmaceuticals NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	268	213	222	241	50.3
Net Total Accounts Receivable
Net Total Receivables	25.8	31.6	38.6	50.6	37.8
Total Inventory
Prepaid Expenses
Total Current Assets	302	253	276	306	102
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	30.2	29.3	30.5	30.3	28.6
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	585	596	806	760	554
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.7	21.8	21.2	195	23.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	191	196	300	303	127
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	394	400	505	457	427
Total Liabilities & Shareholders' Equity	585	596	806	760	554
Total Common Shares Outstanding